Double blind, randomized controlled study to evaluate the efficacy and safety of extract of Aster sphathulifolius Maxim on the glucose metabolism.

Kyung Hee University Hospital at Gangdong0 个研究点目标入组 68 人开始时间: 待定最近更新: 2021年2月23日

试验速览

暂无简介。

•(1) obese (BMI: 25-30 kg/m2), non-diabetic (fasting glucose < 126 mg/dL and HbA1c < 6.5%), and aged 21~65,
•(2) who do not have a treatment history of anti-obesity and/or anti-diabetic medication within 3 months
•(3) who informed and voluntarily consented to participate to the study.

•1)fasting glucose > 126 mg/ml or HbA1c > 6.5%;
•2)subjects who had taken anti-diabetic medication and/or glucocorticoids within 3 months;
•3)had serious illness history, including depression, heart disease, and cancer; drug or alcohol abusers;
•4)had hepatic disease with AST or ALT > 3-fold than normal range; had kidney abnormality with creatinine level > 1.5mg/dL; individuals who need treatment for hyperthyroidism or hypothyroidism.
•5) Those who have been taking glucocorticoids that may affect blood sugar within the last 3 months
•6) Drug abusers or people with history (including alcohol)
•7) Patients with a history of severe disease that may recur during or immediately after the clinical trial
•8) individuals who need treatment for hyperthyroidism or hypothyroidism
•(However, hypothyroidism that does not require treatment with TSH less than 10 µg/dl is not applicable)
•9) Others who are judged to be unable to participate in clinical research

发起方